When the Analog Engine Misfires, Smart Shoppers Pop the Hood

Not every chip needs hype to be helpful. Sometimes the steady, cash-gushing kind stumbles, and that’s when you lean in.

Let’s talk about what’s powering your portfolio and what needs a tune-up.

Strong Edge Found (Sponsored)

Why These 5 Stocks Could Outshine Tech’s Biggest Players

“Nice gains” are fine. But if you’re serious about wealth-building, you don’t want fine—you want transformational.

That’s why our analysts went beyond the noise, screening thousands of companies to uncover 5 rare setups with the potential to deliver massive growth.

And here’s the kicker: past editions of this report have uncovered stocks that went on to post extraordinary runs of +175%, +498%, even +673%.¹

While no one can guarantee the future, history shows these reports have consistently spotted big opportunities before they took off.

For a limited time, you can download 5 Stocks Set to Double—absolutely free.

But there’s urgency: this free access expires at midnight tonight.

[Claim your free copy before time runs out] 

Don’t settle for “nice.” Go after what could be extraordinary.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Never Miss a Stock Alert Again!

We now send our daily picks via SMS too — so you’ll get the same high-conviction ideas, even if you miss the email.

👉 Click here to get stock picks by text and stay in the loop, always.

Medtronic | MDT

Price: $95.24

Big-cap medtech that went through a product drought and is now rolling out fresh gear, with surgical robotics, and ablation systems, while slimming to higher-margin lines.

Dividend is generous, balance sheet is fine, and the pipeline finally has a pulse again.

A game plan here is to buy boredom, sell celebration. Accumulate on quiet weeks, especially if the yield ticks up on dips.

Watch for new product cadence and adoption, margin lift from portfolio mix, and clarity/timing on the diabetes spin.

If operating margin steps up 50–100 bps over a couple quarters, the multiple usually follows.

Why it matters to you: healthcare exposure that’s defensive enough for choppy tapes but has catalysts to re-rate. Think coupon clipper with upside.

Amphenol | APH

Price: $123.75

Connectors and sensors don’t trend on social, but they snap into every growth theme: autos (including EV), aerospace, broadband, cloud, and mobility.

Execution has been stellar, and the stock’s reflected it with a premium multiple.

Don’t chase this stock, but you can plan a ladder.

Start small, then add on pullbacks to the 50-/100-day moving averages or after good quarter, lower guide headlines that spook tourists.

Track the book-to-bill in datacom and auto, pricing vs. input costs, and incremental margins (this is a great operator).

If you want to be cute, pair it with a more cyclical supplier to balance valuation risk.

Why it matters to you: it’s a tollbooth on electrification and bandwidth. As long as more power, more data stays true, pins and sockets get paid.

Position Before It Pops (Sponsored)

7 Q4 Setups That Don’t Wait for Headlines

The final quarter of 2025 will create two groups of people: those who watched their portfolios stagnate (or worse), and those who capitalized on the coming volatility.

Which group will you be in?

Our new report reveals 7 stocks positioned to thrive in the chaos, with specific entry and exit price targets for each.

This is your blueprint to potentially turn market uncertainty into your biggest advantage of the year.

The market's final big move of 2025 is coming.

By the time it's obvious, it will be too late.

Don't get left behind.

Get Your FREE Q4 Stocks Advantage Report Now!

Snap | SNAP

Price: $7.71

The vibes have been rough with this social media outcast. There has been ad pricing pressure, churn pockets in North America, and a stock that can’t catch a sustained bid.

Under the hood, though, subscriptions are scaling, Spotlight engagement is rising, and AR remains the differentiated bet, even if it’s a long runway.

Add this stock but only for the venture sleeve. If you play it, define your risk first.

Use stops just below the recent base, adds only on closes above key moving averages and improving revenue per user. 

Three tells for the company going forward are (1) DAU/MAU quality in North America stabilizing, (2) subscription mix creeping higher, (3) operating leverage returning without starving product.

Optionality exists, but don’t pay for buyout rumors, make the operating case earn its way.

Why it matters to you: This is all about asymmetry. If execution turns and revenue quality improves, the multiple can expand quickly from depressed levels.

If not, you kept it position-sized.

Bank of America | BAC

Price: $51.59

Big money-center bank with a cleaner rate setup as cuts trickle through.

Net interest income stabilizes, fees can perk up, and operating leverage reappears if credit stays orderly. Capital return is a nice tailwind.

This company can be treated like a core financial. Buy on red days when the 10-year spikes; trim into green when yields slide and everything financial rips.

Watch the NII trajectory vs. deposit costs, charge-offs in consumer cards, and expense discipline. 

If management sketches a credible 2026 earnings bridge at Investor Day, the valuation gap to peers can narrow.

Why it matters to you: you get a diversified macro read plus a dividend, and you’re not paying tech-stock prices for it.

Texas Instruments | TXN

Price: $183.73

This one’s the quiet backbone of electronics. They have power management, signal conditioning, and embedded controllers, which means less sizzle, but lots of sockets.

Near term, tariffs and a wobbly auto cycle have zapped some momentum, pushing shares toward a well-watched support zone. 

The offset they have is a fortress free cash flow, a healthy dividend (3% neighborhood), and a habit of buying back stock when the math works.

This stock is like buying quality tools on sale. Start a position near support and stage adds in thirds if it dips through the high-$170s with volume drying up.

Your checklist can be (1) auto order stabilization, (2) industrial backlog trends, (3) gross margin resilience as mix shifts.

If price reclaims the 50-day and holds, a grind back toward the low-$200s is on the table.

For an income angle, enroll in the DRIP and let time do its compounding thing.

Why it matters to you: this is diversified, durable silicon that shows up in everything from factory robots to EVs to data center power rails.

You’re not betting on the one true AI model, you’re betting on electricity behaving.

Today’s basket is about balance: a quality analog franchise on sale (TXN), a medtech stalwart waking up (MDT), a best-in-breed connectors play to ride electrification (APH), a speculative turnaround with optionality (SNAP), and a steadier financial to anchor the macro (BAC). 

Stat of the Day: First New High Since 2021

Last week, small caps finally joined the party. The Russell 2000 notched its first all-time high since November 2021.

When leadership broadens, pullbacks tend to be shallower and rallies stickier.

If this breadth holds, look for quality small/mid industrials, software with real cash flow, and regional banks with strong deposits to quietly outperform while the mega-caps hog headlines.